Literature DB >> 1881970

Plasma catecholamine responses during a personalized physical stress as a dynamic characterization of essential hypertension.

C Tosti-Croce1, C Lucarelli, P Betto, A Floridi, R Rinaldi, A Salvati, F Taggi, F Sciarra.   

Abstract

High performance liquid chromatography (HPLC) with electrochemical detection proves to be a reliable method for determination of plasma catecholamines (CA) to assess the possible role of the sympathetic nervous system (SNS) in essential hypertension (EH). The present investigation in a group of 15 normotensive (N) and 13 stable EH patients, homogeneous for age and duration of hypertension, was carried out without treatment in the supine position, up-right position and during a personalized bicycle exercise. Mean blood pressure, mean heart rate, plasma renin activity and plasma aldosterone were also evaluated at the various exertion phases. Norepinephrine (NE) and epinephrine (E) showed a progressive increase in N and in EH patients, reaching the highest values at maximum effort. However, EH patients showed higher E plasma levels than N before maximum effort. Dopamine (DA) reached the highest values in N at maximum effort and in EH patients at recovery time. These findings allow us to foresee the possibility of a better characterization of the SNS role in EH.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1881970     DOI: 10.1016/0031-9384(91)90302-5

Source DB:  PubMed          Journal:  Physiol Behav        ISSN: 0031-9384


  2 in total

1.  Beta-adrenergic modulation of FMLP- and zymosan-induced intracellular and extracellular oxidant production by polymorphonuclear leukocytes.

Authors:  S Kopprasch; A Gatzweiler; J Graessler; H E Schröder
Journal:  Mol Cell Biochem       Date:  1997-03       Impact factor: 3.396

2.  Hyperreactivity of Salivary Alpha-Amylase to Acute Psychosocial Stress and Norepinephrine Infusion in Essential Hypertension.

Authors:  Lisa-Marie Walther; Roland von Känel; Claudia Zuccarella-Hackl; Petra H Wirtz
Journal:  Biomedicines       Date:  2022-07-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.